SINGAPORE, Aug. 7, 2026 /PRNewswire/ — MetaOptics Ltd (Catalist: 9MT) (“MetaOptics” or the “Company”, and together with its subsidiaries, the “Group”), a Singapore headquartered semiconductor optics company, today announced that it has notified The Nasdaq Stock Market LLC of its withdrawal of its listing application, effective August 7, 2026 (the “Withdrawal”).

“This exercise is a key part of our Company’s strategic plan, aligned with our focus towards our key market and customers in the United States. Against a backdrop of geopolitical uncertainty, recent whiplash in technological stocks’ price performances, ongoing technological disruption, the need for certainty over capital expenditures and intensifying global competition for capital, as well as our obligations to protect shareholder value, we have decided not to proceed with the Proposed Nasdaq Dual Listing at this stage,” said Mr Thng Chong Kim, Executive Chairman of MetaOptics. “The Proposed Nasdaq Dual Listing was always a means, not an end. We remain well-capitalised, with a healthy cash balance. We have also continued to progress on and strengthen our customer engagements and our order book, and at present, we are channelling our capital and management focus into converting our customer pipeline into purchase orders, fulfilling purchase orders and building up our metalens production capacity.”

In reaching its decision, the Company weighed the following factors:

Prevailing geopolitical uncertainties and the resulting volatility in the U.S. capital markets, which has reduced the certainty and timeliness of pricing, undermined the ability to meet fundraising targets and increased execution risks;The pace of technological disruption in the optics and semiconductor value chain alongside intensifying global competition for capital in the semiconductor industry, and the heightened need for certainty over capital expenditures; andThe adverse perception of Asian small-cap issuers arising from a pattern of extreme stock price volatility following the listings of a notable number of such issuers on Nasdaq. Whilst the primary objective of the proposed dual listing on Nasdaq is to provide the Group with access to the U.S. capital markets, support the expansion of its metalens design and fabrication capabilities in the USA and position the Group in close proximity to potential key customers, there can be no assurance that the Company’s securities would not be affected by similar trading activities or schemes. Furthermore, the Company is cognisant of the importance to protect shareholder value, in view of the strong shareholders’ support received since its listing on the Catalist board of the Singapore Exchange in September 2025.

The Company regards this Withdrawal as a deferral rather than a change of ambition, and the Withdrawal does not and will not affect the Company’s strategic focus and operational presence in the U.S. market. The Company will continue to channel its capital and management focus into converting its customer pipeline into purchase orders, fulfilling purchase orders for its key metalens equipment and building up its metalens production capacity.

The Company will also continue to expand its U.S. presence through its subsidiary, MetaOptics Inc. (USA), and the planned deployment of a Direct Laser Writer at the University of Arizona’s Center of Semiconductor Manufacturing. With support and assistance from the Singapore government agencies, the Company is also in the process of establishing its maiden front-end semiconductor fabrication line with 12-inch DUV immersion photolithography equipment in the USA.

The Company may revisit an international dual listing when market conditions are more supportive.

MetaOptics remains listed on the Catalist board of the Singapore Exchange under the ticker 9MT. Shareholders are not required to take any action, and save for professional fees already incurred, the Company does not expect the Withdrawal to have a material impact on its net tangible assets per share or earnings per share for the current financial year ending 31 December 2026.

Business Momentum

The Withdrawal has no bearing on the Group’s business and operations, as well as the execution of its growth plans and strategies. The Company remains well-capitalised, with a healthy cash balance and is focused on continuing its path on (i) accelerating its transition to mass production capabilities as customer engagement moves into active evaluation and volume orders, and (ii) accelerating toward mass adoption of metalens technology in everyday devices:

Consumer Smart Devices

The Company’s second generation pico projector, built around its laser beam scanning optical engine, has drawn encouraging early demand ahead of its inaugural direct-to-consumer sales campaign launch. Since the pre-launch reservation page at https://prelaunch.metaoptics.sg went live in July 2026, the Company has secured close to 200 reservations, with interest from Japan and the United States. The direct-to-consumer sales campaign is currently in its pre-launch phase and is expected to open for general sale in the coming weeks.

In June 2026, the Company also began shipping design/evaluation orders of its metalens 5G smartphone and metalens AI smart glasses to prospective world-class customers in Europe, Japan and the Philippines, and has completed the design of a next-generation 12-megapixel colour metalens camera module which it plans to showcase at CES 2027.

Broadening Customer Pipeline

The aforementioned design/evaluation programme announced in June 2026 places the Company’s metalens modules directly in the hands of leading consumer electronics brands, telecommunications operators and original design manufacturers in Europe, Japan and the Philippines, who are evaluating and qualifying the modules in their own development environments.

Discussions with multinational customers are progressing across smartphones, AR and VR wearables, automotive sensing, co-packaged optics for data centres and biometric identification, including the tunable metalens module for 3D contactless fingerprint sensing being developed with a Singapore national semiconductor research institute. These constructive discussions are at various stages of sampling, qualification and evaluation, and commercial negotiation, and no binding agreement has been entered into to date.

Fulfilment of Purchase Orders

The Company remains focused on fulfilling purchase orders for its key metalens equipment, the Direct Laser Writer (“DLW”) and the 12″ Automatic Metalens Tester, over the next six to twelve months. The Company delivered its Automatic Metalens Tester to its partner in Taoyuan, Taiwan in March 2026, complementing the previously installed DLW in September 2025, providing end-to-end metalens manufacturing and testing capabilities, which further reinforced the Company’s commitment to supporting the region’s advanced semiconductor ecosystems.

In July 2026, the Company signed an agreement to deploy a DLW at the University of Arizona’s Center of Semiconductor Manufacturing, with installation expected to begin in 2027, a critical step in advancing its U.S. expansion strategy and its collaborative research with world-class semiconductor stakeholders in Arizona, and the wider U.S. market.

Supply Chain and Capacity Growth

The Automatic Metalens Tester is co-developed with a listed precision automation and assembly specialist, and the Company is in discussion with a leading European wafer foundry on adoption of the Automatic Metalens Tester within its foundry. Alongside these collaborations, MetaOptics is advancing partnerships covering critical equipment subsystems, wafer-level optics fabrication and the setting up of metalens mass production capacity on its 4-inch and 12-inch DLW platforms, with the aim of shortening lead times, improving yields and supporting mass production volume as design wins are secured.

About MetaOptics Ltd

MetaOptics Ltd (Catalist: 9MT) is a leading semiconductor optics company headquartered in Singapore, specialising in glass-substrate metalens solutions combined with AI-driven image processing. Through advanced optical design and a scalable 12-inch DUV lithography process, MetaOptics supports next-generation applications in co-packaged optics, mobile devices, augmented and virtual reality, automotive electronics and other emerging markets. The Group operates through four vertically integrated business units: capital equipment; metalens design and foundry; IoT and smart devices; and AI algorithms. For more information, visit www.metaoptics.sg.

Forward-Looking Statements

This press release may contain forward-looking statements that involve known and unknown risks, uncertainties and other factors, many of which are beyond the Company’s control. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the Company’s growth strategies, its future business development, results of operations and financial condition, its research and development efforts, its ability to attract and retain customers, and its ability to establish and maintain relationships with suppliers and business partners; and assumptions underlying or related to any of the foregoing. All information provided in this press release is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

For sales enquiries, please contact sales@metaoptics.sg.

Singapore (Headquarters)

MetaOptics Technologies Pte Ltd, 81 Ayer Rajah Crescent, #01-45, Singapore 139967

United States

MetaOptics Inc. (USA), 1 Ferry Building, Suite 201, San Francisco, CA 94111

View original content:https://www.prnewswire.com/apac/news-releases/metaoptics-sharpens-focus-on-metalens-commercialisation-withdraws-nasdaq-listing-application-and-defers-us-dual-listing-plan-302846069.html

SOURCE METAOPTICS LTD

DELRAY BEACH, Fla., Aug. 7, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Care Management Solutions Market is projected to reach USD 42.62 billion by 2031 from USD 22.56 billion in 2026, at a CAGR of 13.6% during the forecast period.

Browse 480 market data Tables and 60 Figures spread through 500 Pages and in-depth TOC on “Care Management Solutions Market – Global Forecast to 2031”

Care Management Solutions Market Size & Forecast:

Market Size Available for Years: 2026–20312026 Market Size: USD 22.56 billion2031 Projected Market Size: USD 42.62 billionCAGR (2026–2031): 13.6%

Care Management Solutions Market Trends & Insights:

The care management solutions (CMS) market is undergoing a significant shift toward a more integrated, patient-centric approach to delivering healthcare services, moving away from its previous fragmented approach. This transition is being driven by the growing adoption of interoperable digital health technologies, cloud computing platforms, and advanced AI/ML models. These advancements enable end users of care management solutions to identify high-risk groups, enhance care coordination, and facilitate better chronic disease management. In light of the ongoing adoption of value-based care and population health management within healthcare systems, demand for care management solutions continues to grow.North America dominated the market, with a share of 50.2% in 2025.By component, the software segment held the largest share (82%) of the care management solutions market in 2025.By deployment model, cloud-based care management solutions held 66% of the market in 2025.By application, chronic care management solutions held 40% of the market in 2025.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19482811

The market is driven by the rapid adoption of value- based care models, a strong emphasis on coordinated, patient- centric care delivery, the growing digital transformation across healthcare systems, and rising demand for integrated platforms that improve clinical outcomes while reducing healthcare costs. Adoption of advanced care management solutions is accelerating due to the increasing prevalence of chronic conditions, aging populations, expanding healthcare data volumes, growing demand for population health management, and rising pressure on end users to enhance care quality and operational efficiency. Healthcare organizations are increasingly moving from standalone care management applications to AI- enabled, interoperable, cloud- based platforms that integrate predictive analytics, risk stratification, remote patient monitoring, patient engagement, workflow automation, and longitudinal care coordination. Enterprise- wide deployment of care management solutions is further supported by government initiatives promoting value- based reimbursement, accountable care, interoperability, and digital health across hospitals, ambulatory care centers, home- based care providers, healthcare payers, and accountable care organizations (ACOs). In addition, increasing investments in artificial intelligence, healthcare analytics, cloud infrastructure, and connected care technologies are creating new growth opportunities for care management solution providers globally. According to the Centers for Medicare & Medicaid Services (CMS), approximately 14. 3 million Medicare beneficiaries were estimated to receive care coordinated through Accountable Care Organizations (ACOs) in 2026, representing a 4. 4.4% increase from 2025. This reflects the continued expansion of value- based and coordinated healthcare delivery models that are driving demand for advanced care management solutions.

The software segment dominated the global care management solutions market in 2025.

The software segment is expected to maintain its leading position throughout the forecast period, driven by the growing adoption of integrated care management platforms that enable care coordination, population health management, condition care management, utilization management, and patient engagement across healthcare organizations. Healthcare providers and payers are increasingly moving from fragmented point solutions to enterprise-wide software platforms that integrate electronic health records (EHRs), claims data, patient-generated health data, analytics, and clinical workflows to support value-based care delivery. The growing adoption of artificial intelligence (AI), predictive analytics, cloud computing, interoperability standards, and workflow automation is further strengthening software capabilities, enabling proactive risk stratification, personalized care planning, and real-time care coordination across the continuum of care. Additionally, increasing investments in healthcare IT modernization, digital health infrastructure, and interoperable healthcare ecosystems are encouraging broader deployment of scalable care management software across hospitals, ambulatory care centers, home-based care providers, and healthcare payers. According to the Centers for Medicare & Medicaid Services (CMS), the CY 2025 Medicare Physician Fee Schedule introduced new Advanced Primary Care Management (APCM) services that support comprehensive care management, care transitions, care coordination, patient-centered care planning, and population-level management, reinforcing the growing adoption of integrated care management software across healthcare organizations.

Rapid expansion of digital healthcare ecosystems and rising demand for coordinated, longitudinal, and patient-centered care are driving strong momentum for the software segment of the care management solutions market. Healthcare organizations are increasingly adopting enterprise care management platforms that integrate care coordination, condition care management, utilization management, population health management, patient engagement, and analytics within unified healthcare environments. Growing adoption of artificial intelligence (AI), predictive analytics, workflow automation, and interoperable cloud-based software is further enabling healthcare providers and payers to identify high-risk patients, personalize care plans, optimize resource utilization, and improve clinical outcomes across the continuum of care. Increasing investments in digital health infrastructure, AI-enabled care management, and connected healthcare ecosystems are expected to further strengthen software segment growth throughout the forecast period.

Healthcare providers held the largest share of the end user segment of the care management solutions market in 2025.

Healthcare providers were the largest end user group in the care management solutions market in 2025, as healthcare delivery increasingly shifted toward continuous, coordinated, and outcomes-focused care. Hospitals, health systems, ambulatory care centers, and home-based care providers are adopting integrated care management platforms to manage complex patient populations, coordinate multidisciplinary care teams, monitor chronic conditions, and improve transitions of care across multiple healthcare settings. The growing use of risk stratification, predictive analytics, patient engagement applications, and remote monitoring technologies is enabling providers to identify care gaps earlier, personalize interventions, and improve resource allocation, while supporting value-based reimbursement models. As healthcare organizations continue to consolidate digital care delivery through unified clinical and administrative workflows, enterprise care management platforms are becoming a critical component of population health strategies, enabling providers to deliver proactive, data-driven, and patient-centric care while enhancing operational efficiency and long-term clinical outcomes.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=19482811

Asia Pacific is expected to witness the fastest growth in the global care management solutions market during the forecast period.

The Asia Pacific region is projected to lead growth in the care management solutions market, driven by rapid healthcare digitization, expanding healthcare infrastructure, rising government investments in digital health, and the adoption of value-based and patient-centric care models across emerging economies. Healthcare providers and payers across the region are accelerating the implementation of integrated care management platforms to improve care coordination, chronic disease and population health management, and patient engagement, while addressing the growing burden of non-communicable diseases and aging populations. Government-led digital health initiatives, expanding health information exchange networks, and growing investments in cloud-based healthcare technologies are further strengthening the regional care management ecosystem. According to the National Health Authority (NHA) of the Government of India, more than 100 crore health records had been successfully linked to Ayushman Bharat Health Account (ABHA) accounts under the Ayushman Bharat Digital Mission (ABDM) by May 2026, demonstrating significant progress toward a longitudinal, interoperable digital health ecosystem that supports coordinated, continuous patient care. This expanding digital infrastructure, together with increasing investments in artificial intelligence, remote patient monitoring, and connected care technologies, is expected to accelerate the adoption of advanced care management solutions across the Asia Pacific region.

Key Players

Leading players in the Behavioural/Mental Health Software companies include Optum (US), Epic Systems Corporation (US), Oracle (US), Koninklijke Philips N.V. (Netherlands), Veradigm LLC (US), and HealthEdge Software, Inc. (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=19482811

Browse Adjacent Market: Healthcare IT Market Research Reports &Consulting

See More Latest Healthcare IT Reports:

Healthcare IT Market by Solution [Clinical (EHR, PHM, PACs & VNA, Telehealth, RCM, CDSS, LIS), Nonclinical (Analytics, RCM, Pharmacy, Interoperability), Service (Claim, Billing, Supply)], End User (Hospital, ASC, Pharmacy, Payer) – Global Forecast to 2031

Revenue Cycle Management (RCM) Market by Offering [Product (Front, Mid, Back-end Solutions), Outsourcing Service], Enterprise Size [Large, SMEs], Technology [AI, Non-AI], End User [Inpatient, Outpatient, Payer, Pharmacy] & Region – Global Forecast to 2030

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/care-management-solutions-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/care-management-solutions.asp

View original content to download multimedia:https://www.prnewswire.com/news-releases/care-management-solutions-market-worth-42-62-billion-by-2031—exclusive-report-by-marketsandmarkets-302845948.html

SOURCE MarketsandMarkets

The Siemon Company, a global leader in high‑performance network infrastructure solutions for data centers and smart buildings, has been recognized as a Great Place To Work® for the fourth consecutive year in the United States. The certification is based entirely on direct employee feedback and reflects the company’s continued focus on building a strong, trust-based workplace culture. This year, 93% of employees said Siemon is a great place to work – a 3-percentage-point increase from last year.

WATERTOWN, Conn., Aug. 7, 2026 /PRNewswire-PRWeb/ — The Siemon Company, a global leader in high‑performance network infrastructure solutions for data centers and smart buildings, has been recognized as a Great Place To Work® for the fourth consecutive year in the United States. The certification is based entirely on direct employee feedback and reflects the company’s continued focus on building a strong, trust-based workplace culture. This year, 93% of employees said Siemon is a great place to work – a 3-percentage-point increase from last year.

Great Place To Work Certification™ is a globally recognized benchmark that celebrates organizations with exceptional workplace cultures. It is awarded based on employee feedback and independent analysis of workplace practices, highlighting companies that foster trust, inclusivity, and high levels of employee engagement.

“Being recognized for the fourth year in a row is something we’re genuinely proud of. It speaks to the kind of company our people have helped build – one grounded in trust, teamwork, and a shared commitment to getting better every year. As a family‑owned business, culture isn’t a program for us; it’s how we operate. Seeing our values of teamwork, quality, innovation and service reflected consistently across our global teams is especially meaningful.”

Henry Siemon, President and CEO of Siemon

About Siemon

Siemon is a global market leader in the design and manufacture of high-performance connectivity solutions for data centers and smart buildings. We empower our customers to connect faster, scale smarter and deploy with confidence. Founded in 1903, our legacy of customer-driven innovation, engineering excellence, and an unwavering commitment to sustainability has made us the benchmark for quality and reliability. We deliver precision-built copper, fiber and high-speed connectivity solutions that perform at scale, with the flexibility, speed, and support our customers rely on. With operations in over 100 countries, Siemon has one of the industry’s broadest solution portfolios and is the trusted partner behind the networks that connect the world. Find out more at www.siemon.com.

Media Contact

Brian Baum, Siemon, 1 8609454200, brian_baum@siemon.com, www.siemon.com

View original content:https://www.prweb.com/releases/siemon-earns-fourth-consecutive-great-place-to-work-certification-302844675.html

SOURCE Siemon